We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Purpose
The purpose of this guidance is to outline the eligibility criteria and process for sponsors to potentially receive reduced fees for major variation applications to registered medicines, specifically for safety-related changes under certain exceptional circumstances.